keyword
https://read.qxmd.com/read/38657265/exagamglogene-autotemcel-for-transfusion-dependent-%C3%AE-thalassemia
#1
JOURNAL ARTICLE
Franco Locatelli, Peter Lang, Donna Wall, Roland Meisel, Selim Corbacioglu, Amanda M Li, Josu de la Fuente, Ami J Shah, Ben Carpenter, Janet L Kwiatkowski, Markus Mapara, Robert I Liem, Maria Domenica Cappellini, Mattia Algeri, Antonis Kattamis, Sujit Sheth, Stephan Grupp, Rupert Handgretinger, Puja Kohli, Daoyuan Shi, Leorah Ross, Yael Bobruff, Christopher Simard, Lanju Zhang, Phuong Khanh Morrow, William E Hobbs, Haydar Frangoul
BACKGROUND: Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis through ex vivo clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene editing of the erythroid-specific enhancer region of BCL11A in autologous CD34+ hematopoietic stem and progenitor cells (HSPCs). METHODS: We conducted an open-label, single-group, phase 3 study of exa-cel in patients 12 to 35 years of age with transfusion-dependent β-thalassemia and a β0 /β0 , β0 /β0 -like, or non-β0 /β0 -like genotype...
April 24, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38657244/sequential-cd7-car-t-cell-therapy-and-allogeneic-hsct-without-gvhd-prophylaxis
#2
JOURNAL ARTICLE
Yongxian Hu, Mingming Zhang, Tingting Yang, Zhuomao Mo, Guoqing Wei, Ruirui Jing, Houli Zhao, Rongrong Chen, Cheng Zu, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Xiaolin Yuan, Qu Cui, Hongshan Guo, Yunxian Yu, Youqin Feng, Chunxiang Jin, Jiangtao Ren, Alex H Chang, Dongrui Wang, He Huang
BACKGROUND: Patients with relapsed or refractory hematologic cancers have a poor prognosis. Chimeric antigen receptor (CAR) T-cell therapy as a bridge to allogeneic hematopoietic stem-cell transplantation (HSCT) has the potential for long-term tumor elimination. However, pre-HSCT myeloablation and graft-versus-host disease (GVHD) prophylaxis agents have toxic effects and could eradicate residual CAR T cells and compromise antitumor effects. Whether the integration of CAR T-cell therapy and allogeneic HSCT can preserve CAR T-cell function and improve tumor control is unclear...
April 25, 2024: New England Journal of Medicine
https://read.qxmd.com/read/38656988/miliutine-c-methyl-ester-a-new-drimane-sesquiterpene-and-bioactive-alkaloids-from-the-stems-of-miliusa-velutina
#3
JOURNAL ARTICLE
Thi Thuy Duong Ngo, Ngoc Phuc Bui, Thi Kieu Loan Vo, Thi My Nuong Nguyen, Hoang Khang Le, Thanh Tung Phan, Poul Erik Hansen, Quang Ton That
Previous results from the our research group have isolated numerous compounds, including novel ones, but the anticancer activity of Miliusa velutina has not been demonstrated. In this study, from the most active ethyl acetate extract of the stems of Miliusa velutina , seven compounds were isolated and determined structures, including a new drimane sesquiterpenoid compound named miliutine C methyl ester ( 1 ) and three bioactive alkaloids ( 5 - 7 ). These three alkaloids ( 5 - 7 ) exhibited strong anticancer activities against various cancer cell lines such as MCF-7, HepG2, HeLa, NCI H460 and normal fibroblasts...
April 24, 2024: Natural Product Research
https://read.qxmd.com/read/38656879/a-novel-prognostic-signature-based-on-cancer-stemness-and-metabolism-related-genes-for-cervical-squamous-cell-carcinoma-and-endocervical-adenocarcinoma
#4
JOURNAL ARTICLE
Yaokai Wang, Yuanyuan Han, Liangzi Jin, Lulu Ji, Yanxiang Liu, Min Lin, Sitong Zhou, Ronghua Yang
BACKGROUND: CESC is the second most commonly diagnosed gynecological malignancy. Given the pivotal involvement of metabolism-related genes (MRGs) in the etiology of multiple tumors, our investigation aims to devise a prognostic risk signature rooted in cancer stemness and metabolism. METHODS: The stemness index based on mRNA expression (mRNAsi) of samples from the TCGA dataset was computed using the One-class logistic regression (OCLR) algorithm. Furthermore, potential metabolism-related genes related to mRNAsi were identified through weighted gene co-expression network analysis (WGCNA)...
April 23, 2024: Aging
https://read.qxmd.com/read/38656653/systematic-literature-review-on-the-incidence-of-herpes-zoster-in-populations-at-increased-risk-of-disease-in-the-eu-eea-switzerland-and-the-uk
#5
JOURNAL ARTICLE
Alen Marijam, Nikki Vroom, Amit Bhavsar, Inga Posiuniene, Nicolas Lecrenier, Hilde Vroling
INTRODUCTION: Older adults and patients with underlying conditions such as immunocompromised (IC) populations (e.g., due to medical conditions or immunosuppressive medication) are at increased risk for herpes zoster (HZ). The first HZ recombinant vaccine for IC patients was approved in 2020. Limited evidence exists to inform decision-makers on HZ incidence in high-risk patients in Europe. This systematic literature review (SLR) assessed HZ incidence across 14 high-risk populations in the European Union/European Economic Area, Switzerland, and the United Kingdom...
April 24, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38656461/role-of-the-sting%C3%A2-pathway-in-myeloid-neoplasms-a-prospero-registered-systematic-review-of-principal-hurdles-of-sting%C3%A2-on-the-road-to-the-clinical-practice
#6
REVIEW
Leticia Rodrigues Sampaio, Ricardo Dyllan Barbosa Dias, João Vitor Caetano Goes, Renata Pinheiro Martins de Melo, Daniela de Paula Borges, Mayara Magna de Lima Melo, Roberta Taiane Germano de Oliveira, Howard Lopes Ribeiro-Júnior, Silvia Maria Meira Magalhães, Ronald Feitosa Pinheiro
Myeloid neoplasms are a group of bone marrow diseases distinguished by disruptions in the molecular pathways that regulate the balance between hematopoietic stem cell (HSC) self-renewal and the generation of specialized cells. Cytokines and chemokines, two important components of the inflammatory process, also influence hematological differentiation. In this scenario, immunological dysregulation plays a pivotal role in the pathogenesis of bone marrow neoplasms. The STING pathway recognizes DNA fragments in the cell cytoplasm and triggers an immune response by type I interferons...
April 24, 2024: Medical Oncology
https://read.qxmd.com/read/38656394/beta-hydroxybutyrate-induces-lung-cancer-cell-death-mitochondrial-impairment-and-oxidative-stress-in-a-long-term-glucose-restricted-condition
#7
JOURNAL ARTICLE
Farzad Izak Shirian, Milad Karimi, Maryam Alipour, Siamak Salami, Mitra Nourbakhsh, Samira Nekufar, Nahid Safari-Alighiarloo, Masoumeh Tavakoli-Yaraki
BACKGROUND: Metabolic plasticity gives cancer cells the ability to shift between signaling pathways to facilitate their growth and survival. This study investigates the role of glucose deprivation in the presence and absence of beta-hydroxybutyrate (BHB) in growth, death, oxidative stress and the stemness features of lung cancer cells. METHODS AND RESULTS: A549 cells were exposed to various glucose conditions, both with and without beta-hydroxybutyrate (BHB), to evaluate their effects on apoptosis, mitochondrial membrane potential, reactive oxygen species (ROS) levels using flow cytometry, and the expression of CD133, CD44, SOX-9, and β-Catenin through Quantitative PCR...
April 24, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38656040/immunogenicity-of-covid-19-adsorbed-inactivated-vaccine-coronavac-and-additional-doses-of-mrna-bnt162b2-vaccine-in-immunocompromised-adults-compared-with-immunocompetent-persons
#8
COMPARATIVE STUDY
Karim Yaqub Ibrahim, Raquel Megale Moreira, Carolina Ferreira Dos Santos, Tânia Mara Varejão Strabelli, Juliana de Cássia Belizário, Maria Isabel de Moraes Pinto, Ana Karolina Barreto Berselli Marinho, Juliana Marquezi Pereira, Liliane Saraiva de Mello, Mauricio Cesar Ando, Vitor Gabriel Lopes da Silva, Paula Keiko Sato, Marcos Alves de Lima, João Italo Dias França, Ana Paula Loch, Karina Takesaki Miyaji, Vanessa Infante, Alexander Roberto Precioso, Ana Marli Christovam Sartori
Inactivated COVID-19 vaccines data in immunocompromised individuals are scarce. This trial assessed the immunogenicity of two CoronaVac doses and additional BNT162b2 mRNA vaccine doses in immunocompromised (IC) and immunocompetent (H) individuals. Adults with solid organ transplant (SOT), hematopoietic stem cell transplant, cancer, inborn immunity errors or rheumatic diseases were included in the IC group. Immunocompetent adults were used as control group for comparison. Participants received two CoronaVac doses within a 28-day interval...
2024: Revista do Instituto de Medicina Tropical de São Paulo
https://read.qxmd.com/read/38655899/condensate-promoting-enl-mutation-drives-tumorigenesis-in-vivo-through-dynamic-regulation-of-histone-modifications-and-gene-expression
#9
JOURNAL ARTICLE
Yiman Liu, Qinglan Li, Lele Song, Chujie Gong, Sylvia Tang, Krista A Budinich, Ashley Vanderbeck, Kaeli M Mathias, Gerald B Wertheim, Son C Nguyen, Riley Outen, Eric F Joyce, Ivan Maillard, Liling Wan
Gain-of-function mutations in the histone acetylation 'reader' ENL, found in AML and Wilms tumor, are known to drive condensate formation and gene activation in cellular systems. However, their role in tumorigenesis remains unclear. Using a conditional knock-in mouse model, we show that mutant ENL perturbs normal hematopoiesis, induces aberrant expansion of myeloid progenitors, and triggers rapid onset of aggressive AML. Mutant ENL alters developmental and inflammatory gene programs in part by remodeling histone modifications...
April 24, 2024: Cancer Discovery
https://read.qxmd.com/read/38655770/re-analysis-of-single-cell-rna-seq-data-reveals-the-origin-and-roles-of-cycling-myeloid-cells
#10
JOURNAL ARTICLE
Jiawei Zhang, Jingsong Shi, Liangge Wang, Xinjie Liu, Zemin Cao, Cihan Ruan, Guangzhi Ning, Shiqing Feng, Xue Yao, Shan Gao
Cycling myeloid cells (CMCs) are often detected from various tissues using single-cell RNA sequencing (scRNA-seq) datasets, however, their research value was not noticed before. For the first time, our study preliminarily revealed the origin, differentiation, and roles of CMCs in physiological processes. Particularly, subgroup a of cycling myeloid cells (aCMCs) were conclusively identified as belonging to a specific cell type. In an active state, aCMCs rapidly proliferate during the early stages of an embryonic development...
April 24, 2024: Stem Cells
https://read.qxmd.com/read/38655094/plasticity-and-resistance-of-cancer-stem-cells-as-a-challenge-for-innovative-anticancer-therapies-do-we-know-enough-to-overcome-this
#11
REVIEW
Agnieszka Knopik-Skrocka, Alicja Sempowicz, Oliwia Piwocka
According to the CSC hypothesis, cancer stem cells are pivotal in initiating, developing, and causing cancer recurrence. Since the identification of CSCs in leukemia, breast cancer, glioblastoma, and colorectal cancer in the 1990s, researchers have actively investigated the origin and biology of CSCs. However, the CSC hypothesis and the role of these cells in tumor development model is still in debate. These cells exhibit distinct surface markers, are capable of self-renewal, demonstrate unrestricted proliferation, and display metabolic adaptation...
2024: EXCLI Journal
https://read.qxmd.com/read/38655053/linc01614-is-a-promising-diagnostic-and-prognostic-marker-in-hnsc-linked-to-the-tumor-microenvironment-and-oncogenic-function
#12
JOURNAL ARTICLE
Xiong Tian, Dali Hu, Na Wang, Lele Zhang, Xuequan Wang
BACKGROUND: Tumor initiation and metastasis influence tumor immune exclusion and immunosuppression. Long non-coding RNA (lncRNA) LINC01614 is associated with the prognosis and metastasis of several cancers. However, the relationship between LINC01614 and cancer immune infiltration and the biofunction of LINC01614 in head and neck squamous cell carcinoma (HNSC) remain unclear. METHODS: The Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) datasets were used to analyze the expression difference and diagnostic value of LINC01614 in normal and tumor tissues...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38654216/modulating-dna-damage-response-in-uveal-melanoma-through-embryonic-stem-cell-microenvironment
#13
JOURNAL ARTICLE
Yingxu Zhang, Jinbiao Zheng, Minyu Chen, Shulun Zhao, Ruiqian Ma, Wenwei Chen, Jiahui Liu
BACKGROUND: Uveal melanoma (UVM) is the most common primary intraocular tumor in adults, with a median survival of 4-5 months following metastasis. DNA damage response (DDR) upregulation in UVM, which could be linked to its frequent activation of the PI3K/AKT pathway, contributes to its treatment resistance. We have reported that embryonic stem cell microenvironments (ESCMe) can revert cancer cells to less aggressive states through downregulation of the PI3K signaling, showing promise in modulating the DDR of UVM...
April 24, 2024: BMC Cancer
https://read.qxmd.com/read/38654128/mesenchymal-stem-cells-as-therapeutic-vehicles-for-glioma
#14
REVIEW
Tomoya Oishi, Shinichiro Koizumi, Kazuhiko Kurozumi
Glioma is a disease with a poor prognosis despite the availability of multimodality treatments, and the development of novel therapies is urgently needed. Challenges in glioma treatment include the difficulty for drugs to cross the blood-brain barrier when administered systemically and poor drug diffusion when administered locally. Mesenchymal stem cells exhibit advantages for glioma therapy because of their ability to pass through the blood-brain barrier and migrate to tumor cells and their tolerance to the immune system...
April 23, 2024: Cancer Gene Therapy
https://read.qxmd.com/read/38654103/circadian-regulation-of-cancer-stem-cells-and-the-tumor-microenvironment-during-metastasis
#15
REVIEW
Yu Wang, Rajesh Narasimamurthy, Meng Qu, Nuolin Shi, Haidong Guo, Yuezhen Xue, Nick Barker
The circadian clock regulates daily rhythms of numerous physiological activities through tightly coordinated modulation of gene expression and biochemical functions. Circadian disruption is associated with enhanced tumor formation and metastasis via dysregulation of key biological processes and modulation of cancer stem cells (CSCs) and their specialized microenvironment. Here, we review how the circadian clock influences CSCs and their local tumor niches in the context of different stages of tumor metastasis...
April 23, 2024: Nature Cancer
https://read.qxmd.com/read/38654072/zeb1-controlled-metabolic-plasticity-enables-remodeling-of-chromatin-accessibility-in-the-development-of-neuroendocrine-prostate-cancer
#16
JOURNAL ARTICLE
Deng Wang, Genyu Du, Xinyu Chen, Jinming Wang, Kaiyuan Liu, Huifang Zhao, Chaping Cheng, Yuman He, Na Jing, Penghui Xu, Wei Bao, Xialian Xi, Yingchao Zhang, Nan Wang, Yiyun Liu, Yujiao Sun, Kai Zhang, Pengcheng Zhang, Wei-Qiang Gao, Helen He Zhu
Cell plasticity has been found to play a critical role in tumor progression and therapy resistance. However, our understanding of the characteristics and markers of plastic cellular states during cancer cell lineage transition remains limited. In this study, multi-omics analyses show that prostate cancer cells undergo an intermediate state marked by Zeb1 expression with epithelial-mesenchymal transition (EMT), stemness, and neuroendocrine features during the development of neuroendocrine prostate cancer (NEPC)...
April 23, 2024: Cell Death and Differentiation
https://read.qxmd.com/read/38654040/rapid-resistance-to-bet-inhibitors-is-mediated-by-fgfr1-in-glioblastoma
#17
JOURNAL ARTICLE
Anna M Jermakowicz, Alison M Kurimchak, Katherine J Johnson, Florence Bourgain-Guglielmetti, Simon Kaeppeli, Maurizio Affer, Hari Pradhyumnan, Robert K Suter, Winston Walters, Maria Cepero, James S Duncan, Nagi G Ayad
Bromodomain and extra-terminal domain (BET) proteins are therapeutic targets in several cancers including the most common malignant adult brain tumor glioblastoma (GBM). Multiple small molecule inhibitors of BET proteins have been utilized in preclinical and clinical studies. Unfortunately, BET inhibitors have not shown efficacy in clinical trials enrolling GBM patients. One possible reason for this may stem from resistance mechanisms that arise after prolonged treatment within a clinical setting. However, the mechanisms and timeframe of resistance to BET inhibitors in GBM is not known...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38654006/cmyc-initiated-hnf1a-as1-overexpression-maintains-the-stemness-of-gastric-cancer-cells
#18
JOURNAL ARTICLE
Ruinan Zhao, Xiangyu Guo, Guohao Zhang, Sen Liu, Ranran Ma, Mengqi Wang, Shiming Chen, Wenjie Zhu, Yuan Liu, Peng Gao, Haiting Liu
Cancer stem cells (CSCs) are believed to be responsible for cancer metastasis and recurrence due to their self-renewal ability and resistance to treatment. However, the mechanisms that regulate the stemness of CSCs remain poorly understood. Recently, evidence has emerged suggesting that long non-coding RNAs (lncRNAs) play a crucial role in regulating cancer cell function in different types of malignancies, including gastric cancer (GC). However, the specific means by which lncRNAs regulate the function of gastric cancer stem cells (GCSCs) are yet to be fully understood...
April 23, 2024: Cell Death & Disease
https://read.qxmd.com/read/38653807/cytogenetic-and-epidemiological-profile-of-chronic-myeloid-leukemia-in-morocco
#19
JOURNAL ARTICLE
Sara Benchikh, Soro Somda Georgina Charlène, Amale Bousfiha, Lunda Razoki, Jamila Aboulfaraj, Latifa Zarouf, Adil El Hamouchi, Abderrahim Malki, Sanaa Nassereddine
Chronic myeloid leukemia (CML) is a neoplastic disease of genetic origin resulting from clonal proliferation of hematopoietic stem cells (HSCs). The reciprocal translocation t(9;22)(q34;q11) is the main chromosomal abnormality involved in this pathology, usually detected by conventional cytogenetics. This article aims to investigate the epidemiological, cytogenetic, therapeutic, and clinical characteristics of Moroccan patients with CML. This research represents the first large-scale study of CML patients in Morocco and was carried out at Institut Pasteur of Morocco...
April 24, 2024: Annals of Hematology
https://read.qxmd.com/read/38653737/targeting-prl-phosphatases-in-hematological-malignancies
#20
REVIEW
Shiyu Xiao, Hongxia Chen, Yunpeng Bai, Zhong-Yin Zhang, Yan Liu
INTRODUCTION: Phosphatase of regenerating liver (PRL) family proteins, also known as protein tyrosine phosphatase 4A (PTP4A), have been implicated in many types of cancers. The PRL family of phosphatases consists of three members, PRL1, PRL2, and PRL3. PRLs have been shown to harbor oncogenic potentials and are highly expressed in a variety of cancers. Given their roles in cancer progression and metastasis, PRLs are potential targets for anticancer therapies. However, additional studies are needed to be performed to fully understand the roles of PRLs in blood cancers...
April 23, 2024: Expert Opinion on Therapeutic Targets
keyword
keyword
2680
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.